Delivery Order SPE2DB20D1100-SPE2DB24FD6G8

Award Date 9/4/24
Potential Completion Date 9/5/24
Potential Value $45K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp for the supply of a pharmaceutical product, the BREYNA 160-4.5 MCG INHALER 10.3GM. The contract has a ceiling value of $1,501.00 and is a firm fixed-price delivery order contract, with a period of performance through July 29, 2024. AmerisourceBergen, a major pharmaceutical distributor, will provide this specialized medical product to support the healthcare needs of the U.S. federal...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $4,980.39 firm fixed-price contract is for the delivery of BREYNA 160-4.5 MCG INHALER 10.3GM, a medical supply product. The contract has an ultimate completion date of May 9, 2024. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of medical supplies, specifically a pharmaceutical product called BREYNA 160-4.5 MCG INHALER 10.3GM. The contract has a ceiling value of $2,972.26 and a period of performance through May 5, 2025. This contract is not set aside and is considered an open competition. Amerisourcebergen...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of the BREYNA 160-4.5 MCG INHALER 10.3GM medical product. The contract has a ceiling value of $13,455.72 and a completion date of June 17, 2024. It is a delivery order contract with a firm-fixed price pricing type. The contract is not designated as a set-aside. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with...
This is a Delivery Order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of a medical inhaler product, specifically the BREYNA 160-4.5 MCG INHALER 10.3GM, with a ceiling value of $9,428.03 and a period of performance through February 6, 2025. The contract is a Firm Fixed Price type and does not have a set-aside designation, indicating open competition....
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $7,270.34, is for the delivery of BREYNA 160-4.5 MCG INHALER 10.3GM medical supplies. The contract is a firm fixed-price delivery order with a completion date of March 19, 2025. The award is not associated with a set-aside designation. Amerisourcebergen Drug Corp holds...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of BREYNA 160-4.5 MCG INHALER 10.3GM, a pharmaceutical product. The contract is a firm fixed-price delivery order with a ceiling value of $1,219.08 and a period of performance through June 30, 2025. This order is not set aside and is part of a larger $999,999,999.00 Indefinite...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of BREYNA 160-4.5 MCG INHALER 10.3GM, a pharmaceutical product. The contract has a firm fixed price pricing type, a ceiling value of $3,147.18, and an ultimate completion date of May 22, 2025. This award is not associated with a set-aside program. Amerisourcebergen Drug Corp holds a...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp for the procurement of BREYNA 80-4.5 MCG INHALER 10.3GM medical supplies. The contract has a ceiling value of $13,590.21 and a completion date of July 12, 2024. It is a firm fixed-price contract with no set-aside designation, indicating open competition. AmerisourceBergen Drug Corp is the prime contractor, and this award is part of the company's Indefinite Delivery Contract (IDC) with...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of a specific medication, BREYNA 160-4.5 MCG INHALER 10.3GM, with a ceiling value of $1,671.62. The contract is a firm fixed-price delivery order, without any set-aside designation, indicating open competition. AmerisourceBergen Drug Corp holds a larger Indefinite Delivery Contract...
  • SPE2DB20D1100
    Indefinite Delivery Contract
  • SPE2DB20D1100-SPE2DB24FD6G8
    Delivery Order

This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of the BREYNA 160-4.5 MCG INHALER 10.3GM medical product. The contract has a ceiling value of $45,304.83 and a period of performance through September 5, 2024. It is a firm fixed-price contract with no set-aside designation. Amerisourcebergen has been awarded numerous federal contracts and indefinite delivery contracts (IDCs) by the DLA and other agencies to provide a wide range of essential pharmaceutical and medical supplies to support military healthcare programs and other government facilities nationwide. These contracts enable efficient procurement of critical care materials and medications to meet the medical needs of military personnel, veterans, and other federal beneficiaries.

Generated 12/4/24, 9:10 AM